SK-124

N/A

Report date: 2022/12/08 11:25:13
NME

Base Information

Drug NameSK-124
Drug Alias NameSK-124
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase SIK2 inhibitorsSalt-inducible kinase 3 inhibitors
TargetsSerine/threonine-protein kinase SIK2Salt-inducible kinase 3
Therapy Area/IndicationsOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHarvard Medical School
China Registration ClassN/A

Develop Information

Active CompaniesHarvard Medical School
Inactive CompaniesN/A
Active IndicationsOsteoporosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A